Evolving Treatment Strategies in Pediatric Leukemia
Webcast
1 AMA PRA Category 1 Credit™ ...OVERVIEW
Evolving Treatment Strategies in Pediatric Leukemia is organized by The Leukemia & Lymphoma Society (LLS).
Recorded on: June 12, 2024
Date of initial release: July 29, 2024
Valid for CME/CE credit through: January 29, 2026
Learning Objectives
After completing this activity, the participant should be better able to:
- Describe common childhood blood cancers, including ALL and AML
- Identify signs and symptoms of childhood blood cancers and diagnostic tests
- Explain treatments, including the role of clinical trials, and LLS PedAL, a precision medicine clinical trial for pediatric acute leukemia
- Describe strategies for management of short- and long-term side effects of treatment
- Explain the importance of following a care plan, including long-term follow-up and communication between the pediatrician/family physician and the pediatric oncologist
- Describe psychosocial concerns related to patients with pediatric cancer
ACCREDITATION & CREDITS
Continuing Education Information
Physician Continuing Medical Education
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The Leukemia & Lymphoma Society. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.0 clinical continuing education credit.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0117. LLS maintains responsibility for the program. Social workers will receive 1.0 clinical CE contact hour for this activity.
Valid for CME/CE credit through: January 29, 2026
TARGET AUDIENCE
PhysicianNursingPhysician AssistantSocial WorkerOncologistsPediatriciansNursesHematologistOther Health ProfessionalsSPECIALITIES
Pediatric Hematology Oncology
Quick Links